CHUC vs HGYN Stock Comparison

Charlie's Holdings and Hong Yuan Holding Prices as of Oct 26, 2026 Peers: Industry group
HGYN Hong Yuan Holding Group
$0.04 0.0% 1M -20.0% 1Y
Market cap
$2.99M
P/E
–
Revenue (TTM)
$559.73K
Div. yield
–
Food Distribution Consumer Staples
1 win

Head to Head

7 decided of 12

Charlie's Holdings leads on 6 of the 12 questions below (Charlie's Holdings 6, Hong Yuan Holding 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionCHUCHGYNLeader
Larger companyMarket capitalisation $41.11M $2.99M CHUC
Cheaper on earningsLower P/E, profitable companies only -21.0x -29.9x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS — — –
Faster revenue growthRevenue growth, trailing twelve months +310.5% +6.1% CHUC
More profitableNet margin, trailing twelve months -7.9% -17.9% CHUC
Better return on capitalReturn on invested capital -47.3% — –
Less leveragedLower net debt / EBITDA -0.6x — –
Higher dividend yieldTrailing dividend yield 0.00% — –
Better 1-year returnPrice return, last 12 months -37.5% -20.0% HGYN
Better 5-year returnAnnualised price return, 5 years -5.6%/yr -27.5%/yr CHUC
Less volatileAnnualised volatility, 1 year 130.1% 349.7% CHUC
Higher overall scoreMean of the five percentile scores vs peers 32/100 11/100 CHUC

Percentile Scorecard

CHUCHGYN

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisCHUCHGYN
Valuation 3 #37 of 38 3 #39 of 40
Growth 47 #19 of 35 24 #29 of 38
Profitability 37 #23 of 36 11 #32 of 36
Financial Health 32 #27 of 39 5 #38 of 40
Shareholder Returns 42 #8 of 13 –
Overall 32 11
  • CHUC ranked among 40 companies in Tobacco and Cannabis
  • HGYN ranked among 41 companies in Staples Retail

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodCHUCHGYNSPY
1 month 0.0%0.0% -0.8%
3 months -11.8%+33.3% +3.5%
6 months -42.3%-60.0% +7.0%
Year to date -50.0%0.0% +12.2%
1 year -37.5%-20.0% +13.0%
3 years +66.7%+100.0% +86.3%
3 years, per year +18.6%+26.0% +23.1%
5 years -25.0%-80.0% +68.6%
5 years, per year -5.6%-27.5% +11.0%
10 years -98.8%— +258.0%
10 years, per year -35.5%— +13.6%

Risk

MeasureCHUCHGYNSPY
Volatility, 1Y 130.1%349.7% 12.7%
Downside volatility, 1Y 156.9%541.5% 12.7%
Beta vs S&P 500, 1Y 0.590.24 1.00
Return / volatility, 1Y -0.29-0.06 1.02
Max drawdown, 5Y -83.3%-95.7% -25.4%
From 52-week high -53.1%-73.3% -1.8%
52-week high $0.32$0.15 $779.14
52-week low $0.09$0.02 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleCHUCHGYN
P/E now vs peer median -21.0xmedian 16.5x -29.9xmedian 22.0x
P/S now vs peer median 1.7xmedian 0.9x 5.3xmedian 0.5x
EV/EBITDA now vs peer median -16.5xmedian 12.3x -33.8xmedian 9.8x
P/FCF now vs peer median -9.5xmedian 23.1x -78.9xmedian 17.8x
P/B now vs peer median 13.4xmedian 1.0x -13.0xmedian 3.0x
PEG now vs peer median -1.27median 0.56 1.29median 1.18

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsCHUCHGYN
Revenue $24.67M $559.73K
Gross profit $6.76M $370.82K
Operating income -$2.67M -$91.58K
Net income -$2.14M -$99.38K
Free cash flow -$4.42M -$37.82K
EPS (diluted) $-0.01 $0.00
Cash & equivalents $527.00K $13.37K
Total debt $9.45M –
Shares (diluted) 274.07M 74.64M
Enterprise value $37.47M $3.02M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricCHUCHGYN
P/E -21.0x -29.9x
P/FCF -9.5x -78.9x
P/Operating cash flow -9.5x -78.9x
P/S 1.7x 5.3x
P/B 13.4x -13.0x
P/Tangible book 13.4x -12.3x
EV/EBITDA -16.5x -33.8x
EV/EBIT -16.4x -32.5x
EV/Revenue 1.8x 5.3x
EV/FCF -9.9x -78.6x
EV/Operating cash flow -9.9x -78.6x
PEG (3Y EPS CAGR) -1.27 1.29

Growth

14 metrics
MetricCHUCHGYN
Revenue growth (1Y) 310.5% 6.1%
Revenue CAGR (3Y) 9.2% –
Gross profit growth (1Y) 233.5% 26.9%
Gross profit CAGR (3Y) – –
Operating income growth (1Y) 22.8% -268.5%
Operating income CAGR (3Y) 5.7% -19.6%
Net income growth (1Y) 22.0% -2,581%
Net income CAGR (3Y) 10.9% -22.9%
EPS growth (1Y) 26.5% -362.0%
EPS CAGR (3Y) 16.6% -23.2%
Operating cash flow growth (1Y) 12.8% 24.4%
Operating cash flow CAGR (3Y) -139.9% –
Free cash flow growth (1Y) 12.8% 24.4%
Free cash flow CAGR (3Y) -121.4% –

Profitability

14 metrics
MetricCHUCHGYN
Gross margin 27.4% 66.2%
EBITDA margin -10.7% -15.7%
Operating margin -10.8% -16.4%
Pretax margin -9.3% -16.4%
Net margin -7.9% -17.9%
FCF margin -17.9% -6.8%
Operating cash flow margin -17.9% -6.8%
Return on equity -68.5% –
Return on assets -15.5% -16.4%
Return on invested capital -47.3% –
Return on capital employed -40.6% –
Asset turnover 1.8x 0.9x
Cash conversion (OCF / net income) 2.1x 0.4x
Stock comp / revenue 0.6% –

Financial Health

11 metrics
MetricCHUCHGYN
Debt / assets 16.8% –
Debt / equity 0.7x –
Net debt / EBITDA -0.6x –
Debt / FCF -0.5x –
Liabilities / assets 75.5% 136.2%
Equity / assets 24.5% -36.2%
Interest coverage -9.9x –
Current ratio 1.7x 0.8x
Quick ratio 0.1x 0.5x
Cash ratio 0.1x 0.0x
Altman Z-score 3.10 -214.31

Shareholder Returns

7 metrics
MetricCHUCHGYN
Dividend yield – –
Net buyback yield -1.9% –
Shareholder yield -1.9% –
Payout ratio (earnings) – –
Payout ratio (FCF) – –
Dividend growth (1Y) – –
Dividend CAGR (3Y) – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusCHUCHGYN

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

CHUCHGYN
CHUC 1.00 0.01
HGYN 0.01 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, CHUC and HGYN?

Charlie's Holdings (CHUC) is the largest by market capitalisation: Charlie's Holdings (CHUC) $41.11M, Hong Yuan Holding (HGYN) $2.99M.

Which company is growing faster?

Charlie's Holdings (CHUC) grew revenue fastest over the trailing twelve months: Charlie's Holdings (CHUC) +310.5%, Hong Yuan Holding (HGYN) +6.1%.

Which company is more profitable?

Charlie's Holdings (CHUC) has the highest net margin (Charlie's Holdings (CHUC) -7.9%, Hong Yuan Holding (HGYN) -17.9%).

Which stock has performed better?

Over the past year Hong Yuan Holding (HGYN) returned the most: Charlie's Holdings (CHUC) -37.5%, Hong Yuan Holding (HGYN) -20.0%. Over five years, Charlie's Holdings (CHUC) compounded fastest (Charlie's Holdings (CHUC) -5.6%/yr, Hong Yuan Holding (HGYN) -27.5%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Charlie's Holdings (CHUC) has been the steadiest (Charlie's Holdings (CHUC) 130.1%, Hong Yuan Holding (HGYN) 349.7%). Volatility measures how widely the price swings, not the risk of the business.

Do CHUC and HGYN move together?

Their daily returns over the past year have a correlation of 0.01, a weak relationship. Holding both diversifies more than two closely linked stocks would.

Which is the better stock, CHUC and HGYN?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Charlie's Holdings (CHUC) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.